Inhibition of the c-Abl–TAp63 pathway protects mouse oocytes from chemotherapy-induced death

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Nature Medicine

• Publication date

  2009-09-27

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/nm.2033PMID 19783996
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• p63 null mutation protects mouse oocytes from radio-induced apoptosis.

  2008cited by this paper
• Yap1 phosphorylation by c-Abl is a critical step in selective activation of proapoptotic genes in response to DNA damage.

  2008cited by this paper
• Yap 1 Phosphorylation by c-Abl Is a Critical Step in Selective Activation of Proapoptotic Genes in Response to DNA Damage

  2008cited by this paper
• Regulation of p73-mediated apoptosis by c-Jun N-terminal kinase.

  2007cited by this paper
• Degradation of p63 by Itch

  2006cited by this paper
• p63 protects the female germ line during meiotic arrest

  2006cited by this paper
• MUC1 oncoprotein blocks nuclear targeting of c‐Abl in the apoptotic response to DNA damage

  2006cited by this paper
• JNK phosphorylation of 14-3-3 proteins regulates nuclear targeting of c-Abl in the apoptotic response to DNA damage

  2005cited by this paper
• The ubiquitin–protein ligase Itch regulates p73 stability

  2005cited by this paper
• The p53 pathway: positive and negative feedback loops

  2005cited by this paper
• The transcriptional coactivator Yes-associated protein drives p73 gene-target specificity in response to DNA Damage.

  2005cited by this paper
• Requirement of caspase-mediated cleavage of c-Abl during stress-induced apoptosis

  2004cited by this paper
• Cell-cycle checkpoints and cancer

  2004cited by this paper
• Pin1 links the activities of c-Abl and p300 in regulating p73 function.

  2004cited by this paper
• Experimental approaches to the study of primordial germ cell lineage and proliferation.

  2004cited by this paper
• c-Abl stabilizes p73 by a phosphorylation-augmented interaction.

  2003cited by this paper
• Functional regulation of p73 and p63: development and cancer.

  2003cited by this paper
• Caspase-Dependent Cleavage of c-Abl Contributes to Apoptosis

  2003cited by this paper
• On the shoulders of giants: p63, p73 and the rise of p53.

  2002cited by this paper
• Regulation of p73 by c-Abl through the p38 MAP kinase pathway

  2002cited by this paper
• Tyrosine phosphorylation of Mdm2 by c‐Abl: implications for p53 regulation

  2002cited by this paper
• Activation of MEK Kinase 1 by the c-Abl Protein Tyrosine Kinase in Response to DNA Damage

  2000cited by this paper
• The DNA damage response: putting checkpoints in perspective

  2000cited by this paper
• A nuclear tyrosine phosphorylation circuit: c‐Jun as an activator and substrate of c‐Abl and JNK

  2000cited by this paper
• The tyrosine kinase c-Abl regulates p73 in apoptotic response to cisplatin-induced DNA damage

  1999cited by this paper
• Interaction of c-Abl and p73alpha and their collaboration to induce apoptosis.

  1999cited by this paper
• ASK1 mediates apoptotic cell death induced by genotoxic stress

  1999cited by this paper
• Interaction of c-Abl and p73α and their collaboration to induce apoptosis

  1999cited by this paper
• p73 is regulated by tyrosine kinase c-Abl in the apoptotic response to DNA damage

  1999cited by this paper
• Determination of cell fate by c-Abl activation in the response to DNA damage

  1998cited by this paper
• p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities.

  1998cited by this paper
• p53, the Cellular Gatekeeper Review for Growth and Division

  1997cited by this paper
• Three distinct signalling responses by murine fibroblasts to genotoxic stress

  1996cited by this paper
• Activation of p38 Mitogen-activated Protein Kinase by c-Abl-dependent and -independent Mechanisms*

  1996cited by this paper
• Detection of platinum-DNA adducts by 32P-postlabelling.

  1995cited by this paper
• c-Abl Activation Regulates Induction of the SEK1/Stress-activated Protein Kinase Pathway in the Cellular Response to 1-β-D-Arabinofuranosylcytosine (*)

  1995cited by this paper
• Female-specific dominant lethal effects in mice.

  1990cited by this paper

• Fertility under fire: how chemotherapy harms the ovaries and the science fighting back?

  2026cites this paper
• Mesenchymal stem cell therapy for premature ovarian insufficiency: progress and challenges.

  2026cites this paper
• Extensive homologous recombination safeguards oocyte genome integrity in mammals

  2025cites this paper
• Decoding premature ovarian insufficiency: A full spectrum review from epidemiology to management with emphasis on cyclophosphamide-evoked ovarian injury.

  2025cites this paper
• DNA damage response signaling in oocytes from an oncofertility perspective.

  2025cites this paper
• The Role of c-Abl in Alzheimer’s Disease: Guilty or not Guilty?

  2025cites this paper
• Fertility Protection in Female Cancer Patients: From Molecular Mechanisms of Gonadotoxic Therapies to Pharmacotherapeutic Possibilities

  2025cites this paper
• Deletion of p63 exon 13 in mice reveals C-terminal isoform–specific functions in epithelial development

  2025cites this paper
• Chromatin remodeler CHD4 establishes chromatin states required for ovarian reserve formation, maintenance and male germ cell survival

  2025cites this paper
• p63: A Master Regulator at the Crossroads Between Development, Senescence, Aging, and Cancer

  2025cites this paper
• Cyclophosphamide chemotherapy induces early p53-directed cytotoxic gene expression changes in ovarian gonadotoxicity

  2025cites this paper
• Chemotherapy accelerated bone ageing is reversed by NMN

  2025cites this paper
• Does gonadotoxic chemotherapy deplete the ovarian reserve through activation of primordial follicles?

  2025cites this paper
• Developments in pharmacotherapy for the preservation of ovarian function during cancer treatment

  2025cites this paper
• Can we really protect the ovary from chemotherapy damage?

  2025cites this paper
• Targeting programmed cell death with natural products: a potential therapeutic strategy for diminished ovarian reserve and fertility preservation

  2025cites this paper
• Oocyte death is triggered by the stabilization of TAp63α dimers in response to cisplatin

  2024cites this paper
• An overview of different methods to establish a murine premature ovarian failure model

  2024cites this paper
• Management of CML and Pregnancy in Low-and Middle-income Countries

  2024cites this paper
• Molecular regulation of DNA damage and repair in female infertility: a systematic review

  2024cites this paper
• 化学疗法所致卵巢损伤的防治研究进展

  2024cites this paper
• A comparative in vitro study on the effect of SGLT2 inhibitors on chemosensitivity to doxorubicin in MCF-7 breast cancer cells.

  2024cites this paper
• Gynotoxic Effects of Chemotherapy and Potential Protective Mechanisms

  2024cites this paper
• Effect of Imatinib Mesylate on the Ovarian Reserves of Female Patients with Chronic Myeloid Leukaemia

  2024cites this paper
• The effect of antitumor therapy on the reproductive system, the possibility of preserving female fertility

  2024cites this paper
• Molecular Mechanisms Determining Mammalian Oocyte Quality with the Treatment of Cancer Therapy.

  2024cites this paper
• Histological assessment for investigation of dose-dependent ovarian toxicity of cyclophosphamide in the rat

  2024cites this paper
• Fertility protection during chemotherapy treatment by boosting the NAD(P)+ metabolome

  2024cites this paper
• Menstrual blood-derived endometrial stem cell, a unique and promising alternative in the stem cell-based therapy for chemotherapy-induced premature ovarian insufficiency

  2023cites this paper
• Summary of the ISFP congress, Brussels, 10–12 November, 2022

  2023cites this paper
• Anti-Mullerian hormone attenuates both cyclophosphamide-induced damage and PI3K signalling activation, while rapamycin attenuates only PI3K signalling activation, in human ovarian cortex in vitro

  2023cites this paper
• Overactivation or Apoptosis: Which Mechanisms Affect Chemotherapy-Induced Ovarian Reserve Depletion?

  2023cites this paper
• A Journey to Reach the Ovary Using Next-Generation Technologies

  2023cites this paper
• The dual role of p63 in cancer

  2023cites this paper
• STEN ameliorates VEGF gene expression by improving XBP1/mRNA-21/mRNA-330 signalling pathways in cisplatin-induced uterus injury in rats

  2023cites this paper
• The future of fertility preservation for women treated with chemotherapy

  2023cites this paper
• Thyroid hormone triiodothyronine does not protect ovarian reserve from DNA damage induced by X-ray and cisplatin

  2023cites this paper
• Chemotherapeutic drugs induced female reproductive toxicity and treatment strategies

  2023cites this paper
• Cancer Treatment-Related Ovarian Dysfunction in Women of Childbearing Potential: Management and Fertility Preservation Options

  2023cites this paper
• Regulation of Oocyte Apoptosis: A View from Gene Knockout Mice

  2023cites this paper
• Heterozygous TP63 pathogenic variants in isolated primary ovarian insufficiency

  2023cites this paper
• Dual suppression of follicle activation pathways completely prevents the cyclophosphamide-induced loss of ovarian reserve.

  2023cites this paper
• The Dominant Mechanism of Cyclophosphamide-Induced Damage to Ovarian Reserve: Premature Activation or Apoptosis of Primordial Follicles?

  2023cites this paper
• Overview of biological effects of melatonin on testis: A review

  2022cites this paper
• Research Progress of p63 Gene and Its Role in Cervical Cancer

  2022cites this paper
• Potential ovarian toxicity and infertility risk following targeted anti-cancer therapies

  2022cites this paper
• Impact of imatinib administration on the mouse ovarian follicle count and levels of intra-ovarian proteins related to follicular quality

  2022cites this paper
• Development of protective agents against ovarian injury caused by chemotherapeutic drugs.

  2022cites this paper
• Distinct interactors define the p63 transcriptional signature in epithelial development or cancer

  2022cites this paper
• The Effect of Chemotherapy on the Ovary Clinical and Pathophysiological Review

  2022cites this paper
• Preserving Oocytes in Oncofertility

  2022cites this paper
• Enhanced pro-apoptosis gene signature following the activation of TAp63α in oocytes upon γ irradiation

  2022cites this paper
• Medical Treatments for Ovarian Protection

  2022cites this paper
• Fertility Preservation Considerations in Female Patients with Benign and Malignant Hematologic Disease

  2022cites this paper
• Germline cell de novo mutations and potential effects of inflammation on germline cell genome stability.

  2022cites this paper
• The effects and mechanism of taxanes on chemotherapy-associated ovarian damage: A review of current evidence

  2022influential citation
• TAp63 determines the fate of oocytes against DNA damage

  2022cites this paper
• Analysis of Secreted Proteins from Prepubertal Ovarian Tissues Exposed In Vitro to Cisplatin and LH

  2022cites this paper
• CHEK2 signaling is the key regulator of oocyte survival after chemotherapy

  2021cites this paper
• Ovaries of patients recently treated with alkylating agent chemotherapy indicate the presence of acute follicle activation, elucidating its role among other proposed mechanisms of follicle loss.

  2021cites this paper
• Senataxin: A New Guardian of the Female Germline Important for Delaying Ovarian Aging

  2021cites this paper
• Female Oncofertility: Current Understandings, Therapeutic Approaches, Controversies, and Future Perspectives

  2021influential citation
• Hot Topics on Fertility Preservation for Women and Girls—Current Research, Knowledge Gaps, and Future Possibilities

  2021cites this paper
• Tyrosine kinase inhibitors protect the salivary gland from radiation damage by increasing DNA double-strand break repair

  2021cites this paper
• Genomic Consideration in Chemotherapy-Induced Ovarian Damage and Fertility Preservation

  2021cites this paper
• Pin1 and JNK1 cooperatively modulate TAp63γ

  2021cites this paper
• Benefits of Nigella sativa Extract Protecting Ovary Due to Cisplatin Chemotherapy

  2021cites this paper
• The effects of recombinant klotho in cisplatin‐induced ovarian failure in mice

  2021influential citation
• p63 expression in granulosa-luteinized cells of infertile patients with peritoneal endometriosis submitted to in vitro fertilization

  2021cites this paper
• Sphingosine-1-phosphate and its mimetic FTY720 do not protect against radiation-induced ovarian fibrosis in the nonhuman primate†

  2021cites this paper
• The role of gonadotropin-releasing hormone agonists in female fertility preservation

  2021cites this paper
• Molecular Mechanism and Prevention Strategy of Chemotherapy- and Radiotherapy-Induced Ovarian Damage

  2021cites this paper
• Adipose-Derived Mesenchymal Stem Cells: A Promising Tool in the Treatment of pre mature ovarian failure.

  2021cites this paper
• Can Some Anticancer Treatments Preserve the Ovarian Reserve?

  2021influential citation
• Cyclophosphamide Exposure Causes Long-Term Detrimental Effect of Oocytes Developmental Competence Through Affecting the Epigenetic Modification and Maternal Factors’ Transcription During Oocyte Growth

  2021cites this paper
• The p63 C-terminus is essential for murine oocyte integrity

  2021cites this paper
• DNA repair in primordial follicle oocytes following cisplatin treatment

  2021cites this paper
• SMG1 and CDK12 Link ΔNp63α Phosphorylation to RNA Surveillance in Keratinocytes.

  2021cites this paper
• Cisplatin decreases HOXA13 and alphaVBeta3 integrin levels in the uterus.

  2021cites this paper
• Evaluating the impacts of emerging cancer therapies on ovarian function

  2021cites this paper
• Dose-dependent effects of ghrelin and aberrant anti-Mullerian hormone levels in the prevention of ovarian damage caused by cisplatin in Wistar-albino rats

  2021cites this paper
• Iron Regulatory Protein 2 Exerts its Oncogenic Activities by Suppressing TAp63 Expression

  2020cites this paper
• Oocytes mount a noncanonical DNA damage response involving APC-Cdh1–mediated proteolysis

  2020influential citation
• Chemotherapy Associated Ovarian Failure

  2020cites this paper
• Involvement of Mfn2, Bcl2/Bax signaling and mitochondrial viability in the potential protective effect of Royal jelly against mitochondria-mediated ovarian apoptosis by cisplatin in rats

  2020cites this paper
• Looking beyond the ovary for oncofertility care in women: uterine injury as a potential target for fertility-preserving treatments

  2020cites this paper
• DNA Damaged Induced Cell Death in Oocytes

  2020cites this paper
• Protective Effects of Imatinib and Ginkgo Biloba on Cisplatin-induced Ovarian Damage in Rats

  2020cites this paper
• Ovarian response to vascular and toxic insults in early life : focus on ovarian reserve and fertility preservation

  2020cites this paper
• Rapamycin preserves the primordial follicle pool during cisplatin treatment in vitro and in vivo

  2020cites this paper
• Impact of imatinib or dasatinib coadministration on in vitro preantral follicle development and oocyte acquisition in cyclophosphamide-treated mice

  2020cites this paper
• The protective effect of platelet-rich plasma administrated on ovarian function in female rats with Cy-induced ovarian damage

  2020cites this paper
• Resveratrol attenuates doxorubicin-induced meiotic failure through inhibiting oxidative stress and apoptosis in mouse oocytes

  2020cites this paper
• A combined proteomic and metabolomic analyses of the priming phase during rat liver regeneration.

  2020cites this paper
• Curcumin and Hesperidin alleviates oxidative stress and hormonal alterations in a rat model of cyclophosphamide-induced premature ovarian failure

  2020cites this paper
• p63-related signaling at a glance

  2020cites this paper
• Implications of non-physiological ovarian primordial follicle activation for fertility preservation.

  2020cites this paper
• Elevated levels of miR-483-5p in oocytes aggravates premature ovarian insufficiency induced by CDDP by targeting the FKBP4

  2020cites this paper
• A tiered female ovarian toxicity screening identifies toxic effects of checkpoint kinase 1 inhibitors on murine growing follicles.

  2020cites this paper
• Melatonin provides protection against cisplatin-induced ovarian damage and loss of fertility in mice.

  2020cites this paper